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BRIEF COMMUNICATION
PREVALENCE OF HEPATITIS C VIRUS INFECTION IN QUILOMBO REMNANT  
COMMUNITIES IN CENTRAL BRAZIL
Nádia R.S. REIS(1), Ana R.C. MOTTA-CASTRO(3), Ágabo M.C. SILVA(1), Sheila A. TELES(2), Clara F.T. YOSHIDA(4) & Regina M.B. MARTINS(1)
SUMMARY
In order to determine the prevalence of hepatitis C virus (HCV) infection in quilombo remnant communities in Central Brazil, 
1,007 subjects were interviewed in all 12 communities existing in Mato Grosso do Sul State, Central Brazil. Blood samples were 
collected and sera were tested for anti-HCV by enzyme-linked immunosorbent assay. Positive samples were retested for confirmation 
using a line immunoassay and were also subjected to HCV RNA detection. The prevalence of HCV infection was 0.2%. This finding 
shows a low prevalence of HCV infection in quilombo remnant communities in Central Brazil.
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INTRODUCTION
Hepatitis C virus (HCV) is a well-known agent of liver diseases, 
including chronic hepatitis, cirrhosis, and hepatocellular carcinoma3. 
HCV infection prevalence (0.01%-20%) and genotypes (1-6) have distinct 
geographical distributions1,10. In Brazil, anti-HCV prevalence among 
blood donors, varied from 0.3% in Santa Catarina State, south region, 
to 5.9% in Amazon region4,8. In the five Brazilian geographical regions, 
genotype 1 has been the most frequently detected2. 
The Brazilian population is descendant mainly from European 
colonizers, Africans, and Amerindians. African individuals were 
introduced to Brazil by slave trade. Some of them escaped from 
gold mines or farms, setting in remote valleys. These runaway-slave 
descendants stayed in communities, called quilombos. Nowadays, there 
are 1,137 communities whose history and tradition allows them to be 
identified as remnants of quilombos. The epidemiological status of HCV 
infection in these communities remains unknown. The objective of this 
study was to determine the prevalence of HCV infection in quilombo 
remnant communities in Central Brazil.
MATERIALS AND METHODS
This study included 1,007 individuals living in all 12 quilombo 
remnant communities in Mato Grosso do Sul State, Central Brazil: 
Furnas dos Dionísios, Jaraguari county (n = 232), São Benedito, Campo 
Grande county (n = 217), Furnas da Boa Sorte, Corguinho county (n 
= 127), Malaquias, Camapuã county (n = 83), Jerônimos, Terenos 
county (n = 71), São Miguel, Maracaju county (n = 49), Orolândia, Rio 
Negro county (n = 49), São Miguel, Nioaque county (n = 47), Furnas 
dos Baianos, Aquidauana county (n = 43), Quintinos, Pedro Gomes 
county (n = 37), Morro do Limão, Campo Grande county (n = 27) and 
Amarelinhos, Sidrolândia county (n = 25). In all communities nearly 
75% of inhabitants were studied. 
The protocol used in the present study was approved by the Ethical 
Committee of the Federal University of Goiás. Informed consent was 
obtained from all participants (or their parents for children). Between 
March 2002 and November 2003, they were interviewed regarding 
demographic characteristics and possible risk factors for HCV 
infection such as history of blood transfusion, surgery, dental treatment, 
acupuncture, tattooing, intravenous drug use, lifetime number of sexual 
partners, sexually transmitted disease, imprisonment and familial 
hepatitis. Blood samples were collected from all individuals and sera 
were stored at -20 ºC.
Serum samples were screened by enzyme-linked immunosorbent 
assay (ELISA) for the presence of anti-HCV antibodies (INNOTEST 
HCV Ab III, Innogenetics NV, Belgium). Positive samples were retested 
for confirmation using a line immunoassay (INNO-LIA HCV Ab III, 
Innogenetics) and were also subjected to RNA extraction, reverse 
transcription, and a nested PCR with primers complementary to the 
conserved area of the 5’ NC region of HCV, essentially as described 
previously6. 
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RESULTS AND DISCUSSION
The population ranged in age from less than one to 108 years (average 
and median: 29.9 and 24 years). Five hundred twenty-seven (52.3%) 
were females and 480 (47.7%) were males. Of the participants, 44% 
were single, 32.8% were married and 23.2% were divorced/separated 
or widowed. The majority of these individuals had a low socioeconomic 
status (40% reported a monthly income less than US$ 200 and the 
remaining between US$ 200 and 600) and level of schooling (80% had 
received eight years or less of formal education). Risk characteristics 
reported by the studied population are shown in Table 1. 
Of the 1,007 studied individuals, six were found to be seropositive 
by ELISA. Of these, two were subsequently confirmed as being positive 
by LIA, one indeterminate and three negative, resulting in an anti-HCV 
prevalence of 0.2% in quilombo remnant communities in Central Brazil. 
All of them were HCV RNA negative. The anti-HCV prevalence found 
in this study is lower than that observed previously among blood donors 
from the same region (1.4%)7, but comparable with those reported in other 
Brazilian rural populations (0-1.7%)5,9. These data suggest that HCV 
infection has a low endemicity in rural populations in Brazil. 
Of the two anti-HCV-positive individuals, one was a 34-year-old man 
from Furnas dos Baianos community who did not mention any known 
source for infection. The other one was a 15-year-old girl from Furnas dos 
Dionísios community who reported previous dental treatment in health 
service in nearby city. However, this factor probably is not related to 
the acquisition of the HCV since the majority of the population (75.3%) 
reported dental treatment in health services in nearby cities and in the 
communities during health campaigns. 
In conclusion, our findings point out a low endemicity for HCV 
infection in quilombo remnant communities in Central Brazil. However, 
owing to the large extension of Brazilian territory, further studies in 
quilombo remnant communities from different geographical regions are 
needed to know the true dimension of epidemiological status of HCV 
infection in these communities in Brazil.
RESUMO
Prevalência da infecção pelo vírus da hepatite C em comunidades 
remanescentes de quilombos no Brasil Central
Com objetivo de estimar a prevalência da infecção pelo vírus da 
hepatite C (HCV) em comunidades remanescentes de quilombos no 
Brasil Central, 1.007 indivíduos foram entrevistados nas 12 comunidades 
quilombolas existentes no Estado de Mato Grosso do Sul, Brasil Central. 
Amostras sanguíneas foram coletadas e os soros testados para anti-HCV 
pelo ensaio imunoenzimático. As amostras positivas foram testadas 
pelo ensaio confirmatório “line immunoassay” e também submetidas 
à detecção do RNA-HCV. A prevalência da infecção pelo HCV foi de 
0,2%. Este achado mostra uma baixa prevalência da infecção pelo HCV 
em comunidades remanescentes de quilombos no Brasil Central. 
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Table 1
Risk characteristics reported by the studied population in quilombo remnant 
communities in Central Brazil
Risk characteristics Reporting risk characteristics 
Number/Total (%)
Blood transfusion 91/1007 (9.0)
Surgery 188/1007 (18.7)
Dental treatment* 758/1007 (75.3)
Acupuncture 3/1007 (0.3)
Tattooing 37/1007 (3.7)
Intravenous drug use 0/1007 (0)
Lifetime number of sexual partners**
0 195/815 (23.9)
1-5 420/815 (51.5)
> 5 200/815 (24.6)
Sexually transmitted disease*** 78/620 (12.6)
Imprisonment 18/1007 (1.8)
Familial hepatitis 265/1002 (26.4)
*Dental treatment was performed in the communities during health campaigns 
and in health services in nearby cities; **The information for this variable is 
based on the individuals aged ≥ 12 years; ***Denominator reflects individuals 
who reported sexual activity.
